Acquiring Company
NYB Holdings Limited
Acquired Company
Nanyang Biologics
Description
RF Acquisition Corp II shareholders approved the merger with NYB Holdings Limited and the transition of Nanyang Biologics to a wholly owned subsidiary. The merger aims to enhance operations and market capabilities. The decision was backed by a strong quorum of shareholders. Final conditions will determine the deal's completion.
Don't miss NYB Holdings Limited's next move
Get an email the moment NYB Holdings Limited makes an acquisition, hires an exec, or expands, usually minutes after it happens.
One email per event. Unsubscribe anytime.
M&A Insights
Based on deal dataFrequently asked
Who acquired Nanyang Biologics?
Nanyang Biologics was acquired by NYB Holdings Limited. The deal was reported on August 22, 2026. NYB Holdings Limited focuses on innovative business solutions across various sectors. The company aims to streamline operations and enhance market opportunities. NYB Holdings Limited is privately held and operates in Artificial Intelligence.
When did NYB Holdings Limited acquire Nanyang Biologics?
NYB Holdings Limited's acquisition of Nanyang Biologics was reported on August 22, 2026. RF Acquisition Corp II shareholders approved the merger with NYB Holdings Limited and the transition of Nanyang Biologics to a wholly owned subsidiary. The merger aims to enhance operations and market capabilities. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Nanyang Biologics do?
Nanyang Biologics specializes in biologics manufacturing with a focus on producing high-quality biological products. The company is known for its advanced technologies in biomanufacturing processes. It is privately held, operating in Manufacturing.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick. $29 a month, billed annually, and if it does not pay for itself in a year we refund it.